| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $9.4M | $8.3M | $7.0M |
| YoY Revenue Growth % | +13.4% | +18.0% | — |
| Gross Profit | $3.0M | $3.3M | — |
| Gross Margin % | 32.0% | 40.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$5.7M | -$3.9M | -$6.7M |
| Operating Margin % | -61.3% | -47.8% | -80.0% |
| Net Income (GAAP) | $5.9M | $4.0M | -$6.4M |
| EBITDA (Normalized) | -$5.7M | -$3.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.1M | -$3.1M | -$6.1M |
| Capital Expenditures (CapEx) | $16.0K | $7.0K | — |
| Free Cash Flow (FCF) | -$5.2M | -$3.1M | -$6.1M |
| FCF Margin % | -55.1% | -37.5% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $2.3M | $4.9M | — |
| Total Debt (Short + Long Term) | $831.0K | $146.0K | — |
| Total Stockholders' Equity | $5.2M | $6.9M | — |